-
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
-
To treat amblyopia, doctors typically prescribe a patch to cover the stronger eye and make the brain learn to work with the weaker one. Virtual reality offers a new approach.
-
Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas.
-
U.S. health inspectors found a host of sanitation and manufacturing problems at an Indian plant that recently recalled eyedrops sold in the U.S.
-
Americans think losing their eyesight would be one of the worst possible health outcomes, yet millions lack a fundamental understanding of eye health.
-
Researchers take a small biopsy from the healthy eye, grow and expand the stem cells in a lab and then transplant them into the injured eye.
-
Kids are focusing too close for too long and their eyes are actually growing to focus the light for things that are near. But it’s blurring their vision for distance.
-
Infections from drug-resistant bacteria have caused death and illness in 68 patients several states, including Florida, the CDC says. The strain has been linked to recalled eyedrops like EzriCare Artificial Tears.
-
Some nasty eye infections in California led health officials to link a superbug bacteria to potentially contaminated eyedrops imported from India. At last count, 58 Americans in 13 states have been infected.
-
Optometrists are lobbying for more leeway to treat patients — and physicians' groups are pushing back. But it's more than a turf war, both sides say, as they explain why patients' vision is at stake.